A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients
Yoshifumi Fujimoto(Hiroshima University), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), T Maekawa(RIKEN Center for Integrative Medical Sciences), Yusuke Nakamura(Rissho University), Hiromitsu Kumada(Toranomon Hospital), C. Nelson Hayes(Hiroshima University), Hidenori Ochi(Hiroshima University), Hiromi Abe(Hiroshima University)
Cited by 20
Related Papers
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804